Search

This new edition is a comprehensive guide to the intricate world of drug discovery and development. It provides readers with an update on basic and novel concepts, approaches and technologies that are used in the discovery and development of new therapeutics for diseases of the central nervous system (CNS). A major aim is to support the education of professionals and specialists in the biomedical neurosciences that will become the innovators, entrepreneurs, and leaders of the future. The educational focus is now enhanced by the inclusion of over 150 study questions available in the free Springer Nature Flashcard App, which makes this a unique book in its field. Divided into five sections, the book starts by introducing concepts and ideas to inspire the next generation of life scientists pursuing careers in drug discovery for CNS diseases. In the following section, key strategies and methods for identifying and testing novel drug targets are described. New chapters on important topics have been added, that is, the blood brain barrier, mass spectrometry, biased signaling and the exposome. The third section highlights strategies and technologies in translational CNS drug discovery and looks at safety and drug metabolism assessment, imaging techniques and functional testing to investigate drug treatment outcomes. The chapters in the fourth section address the emergence of transdiagnostic approaches as exemplified by the Research Domain Criteria initiative and non-invasive brain stimulation techniques. Finally, the book concludes with the late stages of drug development, such as the planning and performance of clinical trials, and regulatory approval. Written by experts from academia and industry, the book covers important fundamentals and best practices as well as current developments in neurotherapeutic research. It offers in-depth insights into the world of drug development and is essential reading for young scientists who are interested in translational research and want to prepare for an academic or industry career in CNS drug discovery.

This richly illustrated textbook delivers a functional vision of dog behaviors. Daily applicable, it offers practical solutions for canine behavioral care with a consistently medical approach to disorders. Readers find a thorough introduction to factors influencing behavior, the canine neuroanatomy and physiology, psychopathologies, as well as treatment options. Drawing on the latest studies in neuroscience, ethology, psychology, and psychiatry, as well as the clinical experience of its expert authors, this guide is both comprehensive and accessible. Multiple clinical case studies illustrate and support presented details on medication and therapies.Behavioral pathology is one of the main challenges in veterinary medicine. Not only are they a cause of suffering for the animal, but they can also affect the quality of the relationship with the pet owners or pose a danger to society. Hence, treatment of these behavioral disorders requires an integrative approach to canine healthand well-being.The book's easy-to-access and descriptive structure allows many audiences to understand a subject area that is all too often considered complex. It addresses veterinary students, practitioners, and future expert veterinarians seeking approach to deep knowledge, as well as all other dog professionals curious to discover a complementary view with respect for the animal and owner.

Encyclopedia of the Human Brain, Second Edition, Seven Volume Set builds on the success of the first edition, providing neuroscience researchers with the ideal'one-stop'resource on all topics related to human brain understanding. Given the length of time since the first edition published, EHB2 is thoroughly revised, with substantial updates on many new and exciting topics, including areas such as human neuroimaging, non-invasive brain stimulation, molecular biology (including genetics and epigenetics), and the clinical diagnoses of brain disorders, along with chapters exploring the introduction of new theoretical and methodological ideas in areas ranging from cognitive neuroscience to evolution of the human brain.In total, there are 440 articles – a vast increase from 224 previously - thus reflecting the huge explosion in neuroscience research during the last 20 years. EHB2 provides a brand new generation of neuroscientists with the perfect tool with which to learn and master the fundamentals of how and why the human brain operates as it does. - Provides a comprehensive and up-to-date resource for exploring the human brain - Includes timely, key topics, providing an excellent overview of the field in a thematically structured one-stop shop location - Moves from an alphabetical structure to a systems/topic approach that is more fruitful for specialized readers and allows easier serendipity to less expert readers

This book reviews the relationship between cytokines, glia, and neurons in the pathophysiology of neuropsychiatric disorders and examines the mechanisms of action of the drugs used for the treatment of these disorders. Increasing evidence has suggested that glia perform important roles in various brain functions, but much remains to be learned about these crucial cells and their interplay with neurons. In addition, a better understanding of the interaction between inflammatory mediators, such as cytokines, and the activated immune response will be of critical importance for the development of new therapeutic strategies. These key areas are the focus of this book, which documents the latest research findings in the field. Evidence is provided for the role of inflammation-induced toxic metabolites from the tryptophan pathway in a wide range of neuropsychiatric disorders, including depression, schizophrenia, and Alzheimer's disease. In presenting state of the art knowledge on the interactions between cytokines, glia, and neurons, the book will help to pave the way for the development of novel targets for the prevention and treatment of neuropsychiatric disorders.

COVID-19 in Alzheimer's Disease and Dementia crucially summarizes the current status of the coronavirus in patients suffering from these conditions, describing why they are a common cause of morbidity among those with COVID-19. The first section includes chapters that provide a general description of COVID-19, including SARS-CoV-2 structure, function, and biology, and its impact on the elderly with chronic conditions include hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases. Also discussed are effects of the virus on the immune system. The second section shifts to the impact of COVID-19 on those with dementia or Alzheimer's disease, with special emphasis on age, gender, ethnic background, and lifestyle. Bringing this focus on neurodegenerative disease in one comprehensive resource, this volume is an essential reference for neuroscientists, clinicians, biomedical scientists, and all others working or interested in the field. - Discusses Alzheimer's disease and dementia as morbidities for COVID-19 - Describes SARS-CoV-2 structure, function, and biology - Examines impact on elderly with chronic conditions including hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases - Covers the effect of race, gender, and sex as additional risk factors

Progress in Brain Research, Volume 278, the latest release in this ongoing serial, highlights new advances in the field with this new volume presenting interesting chapters on Treatment Resistant Depression overview in Adult, Treatment Resistant Depression in Children and Adolescents, Treatment Resistant Depression in Elderly, Headache and Treatment Resistant Depression, Insomnia and Treatment Resistant Depression, Tinnitus and Treatment Resistant Depression, Genetics of Antidepressant Response and Treatment Resistant Depression, Neuroinflammation via Gut-Microbiota-Brain Axis in Treatment Resistant Depression, Molecular Imaging findings for Treatment Resistant Depression, and more. Additional sections cover Functional MRI markers for Treatment Resistant Depression: Insights and Current Challenges, Medication Strategies for Treatment Resistant Depression, Brain Stimulation for Treatment Resistant Depression, Electroconvulsive Therapy for Treatment Resistant Depression, Next Generation Antidepressants with Novel Mechanisms for Treatment Resistant Depression, Psychological aspects and Psychotherapy for Treatment Resistant Depression, and Psychiatric Rehabilitation for Treatment Resistant Depression. - Provides the authority and expertise of leading contributors from an international board of authors - Presents the latest release in Progress in Brain Research serials - Updated release includes the latest information on Treatment-Resistant Depression